selected publications
- Differences in HIV-1 reservoir size, landscape characteristics, and decay dynamics in acute and chronic treated HIV-1 Clade C infection. eLife. 2025 Academic Article GET IT
- Subtypes A1 and D, and recombinant HIV-1 natural polymorphisms associated with lenacapavir drug resistance in Uganda. The Journal of antimicrobial chemotherapy. 2025 Academic Article GET IT
- HIV-1 subtype A1, D, and recombinant proviral genome landscapes during long-term suppressive therapy. Nature communications. 2024 Academic Article GET IT
- Differences in HIV-1 reservoir size, landscape characteristics and decay dynamics in acute and chronic treated HIV-1 Clade C infection. 2024 GET IT
- HIV reservoirs are dominated by genetically younger and clonally enriched proviruses. mBio. 2023 Academic Article GET IT
-
SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8+ T-cells.
Nature communications.
2022
Academic Article
GET IT
Times cited: 20 -
Attenuated HIV-1 Nef But Not Vpu Function in a Cohort of Rwandan Long-Term Survivors.
Frontiers in virology.
2022
Academic Article
GET IT
Times cited: 22 -
Near-Full-Length Single-Genome HIV-1 DNA Sequencing.
Methods in molecular biology (Clifton, N.J.).
2022
Academic Article
GET IT
Times cited: 4 -
Chemistry and Bioinformatics Considerations in Using Next-Generation Sequencing Technologies to Inferring HIV Proviral DNA Genome-Intactness.
Viruses.
2021
Academic Article
GET IT
Times cited: 6 -
Pre-treatment integrase inhibitor resistance is uncommon in antiretroviral therapy-naive individuals with HIV-1 subtype A1 and D infections in Uganda.
AIDS (London, England).
2021
Academic Article
GET IT
Times cited: 12 -
HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapy.
JCI insight.
2021
Academic Article
GET IT
Times cited: 40 -
HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA).
Nature communications.
2021
Academic Article
GET IT
Times cited: 63 -
Variation in HIV-1 Nef function within and among viral subtypes reveals genetically separable antagonism of SERINC3 and SERINC5.
PLoS pathogens.
2020
Academic Article
GET IT
Times cited: 23 -
Blood and Lymph Node Dissemination of Clonal Genome-Intact Human Immunodeficiency Virus 1 DNA Sequences During Suppressive Antiretroviral Therapy.
The Journal of infectious diseases.
2020
Academic Article
GET IT
Times cited: 22 -
Differential Vpu-Mediated CD4 and Tetherin Downregulation Functions among Major HIV-1 Group M Subtypes.
Journal of virology.
2020
Academic Article
GET IT
Times cited: 6 -
Tissue memory CD4+ T cells expressing IL-7 receptor-alpha (CD127) preferentially support latent HIV-1 infection.
PLoS pathogens.
2020
Academic Article
GET IT
Times cited: 29 -
HIV-1 DNA sequence diversity and evolution during acute subtype C infection.
Nature communications.
2019
Academic Article
GET IT
Times cited: 51 -
Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy.
The Journal of clinical investigation.
2019
Academic Article
GET IT
Times cited: 195 -
Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular Immunity.
Journal of virology.
2018
Academic Article
GET IT
Times cited: 17 -
HLA-C downregulation by HIV-1 adapts to host HLA genotype.
PLoS pathogens.
2018
Academic Article
GET IT
Times cited: 21 -
HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers.
The Journal of clinical investigation.
2018
Academic Article
GET IT
Times cited: 62 -
Increasing Prevalence of HIV Pretreatment Drug Resistance in Women But Not Men in Rural Uganda During 2005-2013.
AIDS patient care and STDs.
2018
Academic Article
GET IT
Times cited: 12 -
Anti-apoptotic Protein BIRC5 Maintains Survival of HIV-1-Infected CD4+ T Cells.
Immunity.
2018
Academic Article
GET IT
Times cited: 102 -
Distribution and reduction magnitude of HIV-DNA burden in CD4+ T cell subsets depend on art initiation timing.
AIDS (London, England).
2018
Academic Article
GET IT
Times cited: 3 -
Dolutegravir reshapes the genetic diversity of HIV-1 reservoirs.
The Journal of antimicrobial chemotherapy.
2018
Academic Article
GET IT
Times cited: 7 -
Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals.
PLoS pathogens.
2018
Academic Article
GET IT
Times cited: 76 -
Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study.
2017
GET IT
Times cited: 41 -
Prevalence and clinical impacts of HIV-1 intersubtype recombinants in Uganda revealed by near-full-genome population and deep sequencing approaches.
AIDS (London, England).
2017
Academic Article
GET IT
Times cited: 24 -
Brief Report: Should Abacavir Be a First-Line Alternative for Adults With HIV in Sub-Saharan Africa?.
Journal of acquired immune deficiency syndromes (1999).
2017
Academic Article
GET IT
Times cited: 2 -
Potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of HIV-1 infection.
AIDS (London, England).
2017
Academic Article
GET IT
Times cited: 6 -
Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4+ T cells.
The Journal of clinical investigation.
2017
Academic Article
GET IT
Times cited: 224 -
Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression.
Journal of virology.
2017
Academic Article
GET IT
Times cited: 38 -
In vitro functional assessment of natural HIV-1 group M Vpu sequences using a universal priming approach.
Journal of virological methods.
2016
Academic Article
GET IT
Times cited: 4 -
Non-R5-tropic HIV-1 in subtype A1 and D infections were associated with lower pretherapy CD4+ cell count but not with PI/(N)NRTI therapy outcomes in Mbarara, Uganda.
AIDS (London, England).
2016
Academic Article
GET IT
Times cited: 3 -
Diversity of HIV-1 reservoirs in CD4+ T-cell subpopulations.
Current opinion in HIV and AIDS.
2016
Review
GET IT
Times cited: 55 -
HIV drug resistance testing by high-multiplex "wide" sequencing on the MiSeq instrument.
Antimicrobial agents and chemotherapy.
2015
Academic Article
GET IT
Times cited: 54 -
Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response.
The Journal of antimicrobial chemotherapy.
2015
Academic Article
GET IT
Times cited: 22 -
Reliable genotypic tropism tests for the major HIV-1 subtypes.
Scientific reports.
2015
Academic Article
GET IT
Times cited: 37 -
Prevalence and virologic consequences of transmitted HIV-1 drug resistance in Uganda.
AIDS research and human retroviruses.
2014
Academic Article
GET IT
Times cited: 27 -
Limited evolution of inferred HIV-1 tropism while viremia is undetectable during standard HAART therapy.
PloS one.
2014
Academic Article
GET IT
Times cited: 4 -
Theoretical and experimental assessment of degenerate primer tagging in ultra-deep applications of next-generation sequencing.
Nucleic acids research.
2014
Academic Article
GET IT
Times cited: 28 -
Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes.
Retrovirology.
2013
Academic Article
GET IT
Times cited: 69 -
Comparison of population and 454 "deep" sequence analysis for HIV type 1 tropism versus the original trofile assay in non-B subtypes.
AIDS research and human retroviruses.
2013
Academic Article
GET IT
Times cited: 16 -
Prolonged and substantial discordance in prevalence of raltegravir-resistant HIV-1 in plasma versus PBMC samples revealed by 454 "deep" sequencing.
PloS one.
2012
Academic Article
GET IT
Times cited: 19 -
Convergence of Ser/Thr and two-component signaling to coordinate expression of the dormancy regulon in Mycobacterium tuberculosis.
The Journal of biological chemistry.
2010
Academic Article
GET IT
Times cited: 93